Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Rising Precision Medicine Fuels AI in Genomics Market Growth: Industry to Reach $9.32 Billion by 2030

globenewswire.com
IBM IBM is mentioned as a key player in the AI in genomics market, indicating its involvement in this growing sector. The article does not provide specific performance details for IBM within this context. MSFT Microsoft is listed as a key player in the AI in genomics market. The article highlights its participation in this expanding industry without detailing specific contributions or performance. NVDA NVIDIA is identified as a key player in the AI in genomics market. The article mentions its role in this growing sector but does not offer specific performance metrics or insights.

Rising Precision Medicine Fuels AI in Genomics Market Growth: Industry to Reach $9.32 Billion by 2030 Dublin, June 25, 2026 (GLOBE NEWSWIRE) -- The "AI in Genomics Market Report 2026" has been added to ResearchAndMarkets.com's offering.

The AI in genomics market is experiencing rapid growth, poised to expand from $1.51 billion in 2025 to $2.18 billion in 2026, with a CAGR of 44.6%. This surge is driven by factors like increased availability of large-scale genomic datasets, reduced costs of DNA sequencing, and a rise in genomics research initiatives. Furthermore, collaborations between AI developers and biotech firms and enhanced computational biology capabilities are fueling this expansion.

Looking ahead, the market is projected to reach $9.32 billion by 2030, growing at a CAGR of 43.7%. This growth is supported by the adoption of precision medicine, investment in AI-powered drug discovery, and the expansion of population genomics projects. The demand for personalized healthcare and advancements in deep learning genomic models further bolster the market's trajectory. Key trends include AI-driven genome analysis platforms, machine learning for variant detection, and integration of AI in gene editing workflows.

The rise of personalized medicine is pivotal in driving market growth, especially as the prevalence of chronic diseases necessitates tailored treatments. AI supplements personalized medicine by analyzing complex genetic data, paving the way for individualized patient care. Notably, the FDA's approval of 16 new personalized treatments for rare disease patients in 2023 underscores this trend.

Innovation is a focal point for major companies in the AI genomics market, with a strong emphasis on developing drug discovery platforms. These platforms leverage AI to enhance precision healthcare and research efficacy. For instance, Genomic Vision launched FiberSmart in March 2023, an AI-powered platform for analyzing long DNA fibers, aiming to improve diagnosis accuracy and treatment efficacy.

A significant industry development includes SeqOne S.A.S.'s acquisition of Congenica in 2025, enhancing its global standing in AI-powered genomic medicine through advanced AI analytics combined with clinical interpretation services.

The AI in genomics market is populated by key players such as IBM, Microsoft, NVIDIA, Deep Genomics, and BenevolentAI, among others. North America leads the market as of 2025, while Asia-Pacific is identified as the fastest-growing region. Countries covered include the USA, UK, China, Germany, Japan, and more.

However, tariffs are affecting the market by inflating costs for imported genomic data processing hardware, notably impacting North America and Europe, while spurring local hardware production and regional cloud infrastructure deployment.

This market research report provides extensive insights into AI in genomics market statistics, including market size, regional shares, segmentation, trends, and opportunities, offering a comprehensive view of the industry's current and future landscape.

The AI in genomics sector comprises hardware, software, and services, utilizing machine learning and computer vision technologies. The primary functionalities include genome sequencing and gene editing, applied in drug discovery and precision medicine. Major end-users encompass pharmaceutical companies, healthcare providers, and research centers, underlining the market's expansive reach.

The "AI in Genomics Market Global Report 2026" is an essential resource for strategists, marketers, and senior management seeking critical insights into the current and future trends shaping this rapidly expanding market. With a focus on the burgeoning AI in genomics sector, this report offers a roadmap for the upcoming decade, illuminating the key forces that will drive market transformation.

Reasons to Purchase:

Report Overview:

The "AI in Genomics Market Global Report" delves into pivotal questions about the largest and most rapidly expanding markets, their economic significance, and cross-market relations. It addresses technological, regulatory, and consumer preference shifts poised to impact the market. Covering market attributes, dimensions, growth, segmentation, and geography-based analyses, the report provides a holistic view of historical and predicted market progressions.

Scope and Segmentation:

The report categorizes data by components, technologies, functionalities, applications, and end-users, with subcategories providing specific insights into hardware, software, and services. Comprehensive geographical coverage spans significant global regions and countries.

Companies and Markets:

Prominent companies featured include IBM, Microsoft, NVIDIA, Deep Genomics, BenevolentAI, Fabric Genomics, and more, covering markets such as drug discovery, precision medicine, and diagnostic applications.

Delivery Formats: Word, PDF, or Interactive Report with Excel Dashboard. Additional benefits include bi-annual data updates, customization, and expert consultant support.

Key Attributes:

Companies Featured

The companies featured in this AI in Genomics market report include:

For more information about this report visit https://www.researchandmarkets.com/r/ewbtxx

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment